BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 16550042)

  • 1. Liver transplantation: an update.
    Said A; Lucey MR
    Curr Opin Gastroenterol; 2006 May; 22(3):272-8. PubMed ID: 16550042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation: an update 2007.
    Said A; Einstein M; Lucey MR
    Curr Opin Gastroenterol; 2007 May; 23(3):292-8. PubMed ID: 17414845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status and future of liver transplantation.
    Merion RM
    Semin Liver Dis; 2010 Nov; 30(4):411-21. PubMed ID: 20960380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MELD may not be the better system for organ allocation in liver transplantation patients in Singapore.
    Lee YM; Fernandez M; Da Costa M; Lee KH; Sutedja DS; Tai BC; Tan KC; Isaac J; Prabhakaran K; Lim SG
    Singapore Med J; 2006 Jul; 47(7):592-4. PubMed ID: 16810430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.
    Schaffer RL; Kulkarni S; Harper A; Millis JM; Cronin DC
    Liver Transpl; 2003 Nov; 9(11):1211-5. PubMed ID: 14586883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of the OPTN/UNOS Liver Transplant Registry.
    Waki K; Tamura S; Sugawara Y; Yamashiki N; Kadowaki T; Kokudo N
    Clin Transpl; 2009; ():55-64. PubMed ID: 20524276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplantation: an update 2008.
    Said A; Lucey MR
    Curr Opin Gastroenterol; 2008 May; 24(3):339-45. PubMed ID: 18408462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MELD-based liver allocation: who is underserved?
    Biggins SW; Bambha K
    Semin Liver Dis; 2006 Aug; 26(3):211-20. PubMed ID: 16850370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival benefit after liver transplantation: a single European center experience.
    Ravaioli M; Grazi GL; Dazzi A; Bertuzzo V; Ercolani G; Cescon M; Cucchetti A; Masetti M; Ramacciato G; Pinna AD
    Transplantation; 2009 Sep; 88(6):826-34. PubMed ID: 19920783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplant considerations for evaluation, CTP, and MELD.
    Mathews SB; Allison W; Lin S
    Crit Care Nurs Clin North Am; 2010 Sep; 22(3):403-11. PubMed ID: 20691390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation in the United States.
    Qiu J; Ozawa M; Terasaki PI
    Clin Transpl; 2005; ():17-28. PubMed ID: 17424722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model for end-stage liver disease score-based allocation of donors for liver transplantation: a spanish multicenter experience.
    de la Mata M; Cuende N; Huet J; Bernardos A; Ferrón JA; Santoyo J; Pascasio JM; Rodrigo J; Solórzano G; Martín-Vivaldi R; Alonso M
    Transplantation; 2006 Dec; 82(11):1429-35. PubMed ID: 17164713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged waiting times for liver transplantation in obese patients.
    Segev DL; Thompson RE; Locke JE; Simpkins CE; Thuluvath PJ; Montgomery RA; Maley WR
    Ann Surg; 2008 Nov; 248(5):863-70. PubMed ID: 18948816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?
    Austin MT; Poulose BK; Ray WA; Arbogast PG; Feurer ID; Pinson CW
    Arch Surg; 2007 Nov; 142(11):1079-85. PubMed ID: 18025337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans.
    Ahmad J; Downey KK; Akoad M; Cacciarelli TV
    Liver Transpl; 2007 Nov; 13(11):1564-9. PubMed ID: 17969210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
    Thuluvath PJ; Maheshwari A; Thuluvath NP; Nguyen GC; Segev DL
    Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographic disparities in deceased donor liver transplantation within a single UNOS region.
    Barshes NR; Becker NS; Washburn WK; Halff GA; Aloia TA; Goss JA
    Liver Transpl; 2007 May; 13(5):747-51. PubMed ID: 17457866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement?
    Roayaie K; Feng S
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S36-43. PubMed ID: 17969067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.